BACKGROUND: The aim of this study was to investigate whether nanomolar concentrations of lanthanum could influence the calcium-sensing receptor (CaSR) response. METHODS: Embryonic kidney (HEK-293) cells transiently transfected with the human CaSR were used to test the ability of lanthanum to activate the CaSR, either alone or in combination with calcium. CaSR activation was measured by flow cytometry. Parathyroid glands from 4-month-old male Wistar rats with normal renal function (n = 60) were also cultured ex vivo with different concentrations of lanthanum to measure parathyroid hormone (PTH) secreted to the medium and PTH mRNA. RESULTS: The maximal CaSR activation induced by 1 muM lanthanum chloride (LaCl(3)) was similar to that induced by 16 mM calcium chloride (CaCl(2) 16 mM: 294 +/- 14%; LaCl(3) 1 muM: 303 +/- 11%). Lanthanum half effective concentration (EC(50)) was 77.28 nM, lower than the 2.30 mM obtained for calcium, supporting the concept that this metal is a strong agonist of the CaSR. Moreover, lanthanum was also able to enhance CaSR sensitivity to calcium. The presence of 1 nM LaCl(3) significantly left-shifted the CaSR response curve, changing the EC(50) value for calcium from 2.30 mM (calcium alone) to 1.26 mM (calcium + 1 nM lanthanum). The parathyroid glands cultured with lanthanum showed a trend to secrete less PTH compared to the control glands: 1.51 +/- 0.23 (control), 0.91 +/- 0.17 (La 100 nM) and 1.04 +/- 0.18 (La 400 nM) [(pg/h)/(pg/h), mean +/- SEM] (ANOVA P = 0.0145). A similar trend was also observed in PTH synthesis measured by PTH mRNA levels. CONCLUSIONS: These in vitro findings demonstrate that lanthanum, at nanomolar concentrations, is an agonist of the CaSR able to activate it in the absence of calcium. In addition, it can also enhance CaSR sensitivity to calcium, modulating PTH synthesis and secretion.
BACKGROUND: The aim of this study was to investigate whether nanomolar concentrations of lanthanum could influence the calcium-sensing receptor (CaSR) response. METHODS:Embryonic kidney (HEK-293) cells transiently transfected with the humanCaSR were used to test the ability of lanthanum to activate the CaSR, either alone or in combination with calcium. CaSR activation was measured by flow cytometry. Parathyroid glands from 4-month-old male Wistar rats with normal renal function (n = 60) were also cultured ex vivo with different concentrations of lanthanum to measure parathyroid hormone (PTH) secreted to the medium and PTH mRNA. RESULTS: The maximal CaSR activation induced by 1 muM lanthanum chloride (LaCl(3)) was similar to that induced by 16 mM calcium chloride (CaCl(2) 16 mM: 294 +/- 14%; LaCl(3) 1 muM: 303 +/- 11%). Lanthanum half effective concentration (EC(50)) was 77.28 nM, lower than the 2.30 mM obtained for calcium, supporting the concept that this metal is a strong agonist of the CaSR. Moreover, lanthanum was also able to enhance CaSR sensitivity to calcium. The presence of 1 nM LaCl(3) significantly left-shifted the CaSR response curve, changing the EC(50) value for calcium from 2.30 mM (calcium alone) to 1.26 mM (calcium + 1 nM lanthanum). The parathyroid glands cultured with lanthanum showed a trend to secrete less PTH compared to the control glands: 1.51 +/- 0.23 (control), 0.91 +/- 0.17 (La 100 nM) and 1.04 +/- 0.18 (La 400 nM) [(pg/h)/(pg/h), mean +/- SEM] (ANOVA P = 0.0145). A similar trend was also observed in PTH synthesis measured by PTH mRNA levels. CONCLUSIONS: These in vitro findings demonstrate that lanthanum, at nanomolar concentrations, is an agonist of the CaSR able to activate it in the absence of calcium. In addition, it can also enhance CaSR sensitivity to calcium, modulating PTH synthesis and secretion.
Authors: James Varani; Shannon D McClintock; Randall N Knibbs; Isabelle Harber; Dania Zeidan; Mohamed Ali H Jawad-Makki; Muhammad N Aslam Journal: Front Nutr Date: 2022-05-11
Authors: Shannon D McClintock; Justin A Colacino; Durga Attili; Michael K Dame; Aliah Richter; Anusha R Reddy; Venkatesha Basrur; Areeba H Rizvi; D Kim Turgeon; James Varani; Muhammad N Aslam Journal: Cancer Prev Res (Phila) Date: 2018-04-10
Authors: Shannon D McClintock; Durga Attili; Michael K Dame; Aliah Richter; Sabrina S Silvestri; Maliha M Berner; Margaret S Bohm; Kateryna Karpoff; Caroline L McCarthy; Jason R Spence; James Varani; Muhammad N Aslam Journal: PLoS One Date: 2020-03-05 Impact factor: 3.240
Authors: Muhammad N Aslam; Shannon D McClintock; Mohamed Ali H Jawad-Makki; Karsten Knuver; Haris M Ahmad; Venkatesha Basrur; Ingrid L Bergin; Suzanna M Zick; Ananda Sen; D Kim Turgeon; James Varani Journal: Nutrients Date: 2021-03-14 Impact factor: 5.717
Authors: Urszula Marzec-Wróblewska; Piotr Kamiński; Paweł Łakota; Grzegorz Ludwikowski; Marek Szymański; Karolina Wasilow; Tomasz Stuczyński; Adam Buciński; Leszek Jerzak Journal: Arch Environ Contam Toxicol Date: 2015-03-12 Impact factor: 2.804